In 2021, a technology developed at University of Michigan, called Seq-Scope, revolutionized the ability to map gene activity ...

Gene therapy has been successfully used to treat a number of diseases, including immune deficiencies, hereditary blindness, ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how ...

A study reveals how two proteins cooperate in a key early step of antiviral detection, as reported by researchers at Science ...

Vaxxas has been awarded a tender by the European Health and Digital Executive Agency to help develop next-generation ...

A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving ...

Yonsei University researchers have developed a system for combining the benefits of planar array platforms with those of ...

SK-IDT-Vaxxas consortium establishes strategic entry point for high-density microarray patch (HD-MAP) vaccines in Europe to improve vaccine performance and access.Parallel development of ...

The company has shed its former “GenEdit” name and strategy in favor of a plan to develop its own medicines, starting with a ...

The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...

In India, rare diseases are not so rare. It is estimated that around 70 million Indians live with one of more than 7,000 rare diseases, many of which are genetic […] ...

Increase in prevalence of genetic disorders, shift towards personalized medicine, and surge in demand for forensic DNA analysis are the major factors which drive the global genotyping market ...